课题基金 / 基金详情

Investigation of molecular mechanisms for common diseases caused by aging and oxidative stress and development of drug candidates aiming the molecular targets

Investigation of molecular mechanisms for common diseases caused by aging and oxidative stress and development of drug candidates aiming the molecular targets
衰老和氧化应激引起的常见疾病的分子机制研究以及针对分子靶点的候选药物开发
批准号:
15390029
负责人:
NAKAYAMA Hitoshi
金额:
$9.73万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2005

项目摘要

项目成果

NAKAYAMA Hitoshi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In this project we aim to investigate the molecular mechanisms for adipocytokine production from adipocytes and clearance of β-amyloid peptide in microglia, which apply to develop drug candidates aiming the molecular targets. During the passed three years, we have obtained several novel findings and drug candidates as follows. (1)Production of some adipocytokines including resistin increased by stimulation of ox-LDL via translation modulated mechanism. (2)We found a novel clearance mechanism of oligomeric β-amyloid peptides, which is induced selectively in type-2 microglia by IL-4 stimulation. (3)The clearance mechanism was proved to induce in vivo using transgenic AD model mice. We also found that some compounds of low molecular weight are able to induce the clearance mechanism. (4)We are succeeded in generating specific monoclonal antibodies to discriminate type-1 and type-2 microglia (Patent is applied.)All the results described above are more than we expected, and they are very promising to create new drugs for recovering from Alzheimer's disease, in particular.
期刊论文(12)
专著(0)
科研奖励(0)
会议论文
K.Furukawa, et al.: "Adiponectin down-regulates acyl-coenzyme A : cholesterol acyltransferase-1 in human monocyte-derived macrophages"Biochem.Biophys.Res.Commun.. (in press). (2004)
K.Furukawa 等人:“脂联素下调酰基辅酶 A:人单核细胞来源的巨噬细胞中的胆固醇酰基转移酶 1”Biochem.Biophys.Res.Commun.(出版中)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Proteasomal degradation of Kir6.2 channel protein and its inhibition by Na^+ channel blocker aprindine.
Kir6.2 通道蛋白的蛋白酶体降解及其 Na+ 通道阻断剂阿普林定的抑制。
DOI: --
发表时间: 2005
期刊: Biochem.Biophys.Res.Commun. 331
影响因子: --
作者: [Tanaka, H. et al.]
通讯作者: H. et al.
DOI: --
发表时间: 2005
期刊: J.Biol.Chem. 280
影响因子: --
作者: [M.Katsuki, et al.]
通讯作者: et al.
Characterization of benzodiazepine binding site on human α-1-acid glycoprotein.
人 α-1-酸性糖蛋白上苯二氮卓结合位点的表征。
DOI: --
发表时间: 2005
期刊: Biochim.Biophys.Acta 1725
影响因子: --
作者: [Chuang, V.T.G.et al.]
通讯作者: V.T.G.et al.
12
    The glycosphingolipid-mediated recognition of mycobacteria by human phagocytes
    • 批准号:
      25860831
    • 项目类别:
      Grant-in-Aid for Young Scientists (B)
    • 资助金额:
      $2.41万
    • 财政年份:
      2013
    • 负责人:
      NAKAYAMA Hitoshi
    • 依托单位:
    Semantic and Pragmatic Studies in the Relationship Between the English Relative Clause and Its Main Clause
    • 批准号:
      24520548
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.33万
    • 财政年份:
      2012
    • 负责人:
      NAKAYAMA Hitoshi
    • 依托单位:
    Pragmatic Studies in Exceptional English Usage : Interpretation of Subordinate Clauses
    • 批准号:
      20520443
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.33万
    • 财政年份:
      2008
    • 负责人:
      NAKAYAMA Hitoshi
    • 依托单位:
    Development of novel anti-atheroscleroic agents
    • 批准号:
      12557220
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $7.94万
    • 财政年份:
      2000
    • 负责人:
      NAKAYAMA Hitoshi
    • 依托单位:
    国内基金
    海外基金
    支链氨基酸代谢紊乱调控“Adipocytes - Macrophages Crosstalk”诱发2型糖尿病脂肪组织功能和结构障碍的作用及机制